English to Russian Science Chemistry; Chem Sci/Eng

The creatine kinase MB (MBI) method is an in vitro diagnostic test for the quantitative measurement of creatine kinase MB isoenzyme activity in human serum and plasma on the ABC clinical chemistry system.
Summary:
The ABC MBI method is a modification of the International Federation of Clinical Chemistry (IFCC) creatine kinase (CK) *primary reference 37°C procedure*, adapted for use on the ABC clinical chemistry system.
The MB isoenzyme of creatine kinase is used as a marker of cardiac muscle cell damage, and may be especially useful to detect re-infarction after a prior event.
Normally an intracellular enzyme, CK-MB begins to appear in blood about 4 to 6 hours after the onset of myocardial damage, peaking at about 24 hours after a single event.